Patent · US Active

Method for treating liver cirrhosis or interstitial pulmonary fibrosis

US7655628B2 · kind B2 · utility

1Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2007
Grant dateFeb 2, 2010
Priority date
Expiry dateMar 11, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of SARP-1 for the preparation of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.